Resveratrol inhibits BMP-4-stimulated VEGF synthesis in osteoblasts: Suppression of S6 kinase

International Journal of Molecular Medicine

Volumn 33, Issue 4, 2014, Pages 1013-1018

  Kondo, Akira ^a,b   Otsuka, Takanobu ^a   Kuroyanagi, Gen ^a,b   Yamamoto, Naohiro ^a,b   Matsushima Nishiwaki, Rie ^b   Mizutani, Jun ^a   Kozawa, Osamu ^b   Tokuda, Haruhiko ^b,c  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Bone morphogenetic protein 4; Osteoblast; Resveratrol; Vascular endothelial growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; RESVERATROL; S6 KINASE; SIRTUIN; SIRTUIN 1; SIRTUIN 1720; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; INTRACELLULAR SIGNALING; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL LINE; GENE EXPRESSION REGULATION; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MICE; OSTEOBLASTS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; SMAD PROTEINS; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899516931     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1626     Document Type: Article

References (30)

1. Karsenty G and Wagner EF: Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406, 2002. (Pubitemid 34436569)
2. Boyce BF and Xing L: Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473: 139-146, 2008.
3. Parfitt AM: Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30: 5-7, 2002.
4. Miyazono K, Maeda S and Imamura T: BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16: 251-263, 2005. (Pubitemid 40910315)
5. Krause C, de Gorter DJJ, Karperien M and ten Dijke P: Signal transduction cascades controlling osteoblast differentiation. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Rosen CJ (ed). 7th edition. American Society for Bone and Mineral Research, Washington, pp10-16, 2008.
6. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H and Matsumoto K: XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18: 179-187, 1999. (Pubitemid 29005034)
7. Clarkin CE and Gerstenfeld LC: VEGF and bone cell signalling: an essential vessel for communication? Cell Biochem Funct 31: 1-11, 2013.
8. Kozawa O, Matsuno H and Uematsu T: Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J Cell Biochem 81: 430-436, 2001. (Pubitemid 32405760)
9. Tokuda H, Hatakeyama D, Shibata T, Akamatsu S, Oiso Y and Kozawa O: p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am J Physiol Endcrinol Metab 284: E1202-E1209, 2003. (Pubitemid 36617468)
10. Jankun J, Selman SH, Swiercz R and Skrzypczak-Jankun E: Why drinking green tea could prevent cancer. Nature 387: 561, 1997. (Pubitemid 27248750)
11. Harborne JB and Williams CA: Advances in flavonoid research since 1992. Phytochemistry 55: 481-504, 2000.
12. Blander G and Guarente L: The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435, 2004. (Pubitemid 39050375)
13. Koo SH and Montminy M: In vino veritas: a tale of two sirt1s? Cell 127: 1091-1093, 2006.
14. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R and Sinclair DA: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006. (Pubitemid 44764104)
15. Mizutani K, Ikeda K, Kawai Y and Yamori Y: Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 253: 859-863, 1998. (Pubitemid 29039235)
16. Kupisiewicz K, Boissy P, Abdallah BM, Hansen FD, Erben RG, Savouret JF, Søe K, Andersen TL, Plesner T and Delaisse JM: Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts. Calcif Tissue Int 87: 437-449, 2010.
17. Sudo H, Kodama HA, Amagai Y, Yamamoto S and Kasai S: In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96: 191-198, 1983. (Pubitemid 13155577)
18. 2 in osteoblast-like cells. Exp Cell Res 198: 130-134, 1992.
19. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
20. Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O and Asano T: Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem 66: 946-950, 1996. (Pubitemid 26065890)
21. Bradamante S, Barenghi L and Villa A: Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188, 2004. (Pubitemid 39391187)
22. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ and Westphal CH: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716, 2007. (Pubitemid 350207685)
23. Miyazawa K, Shinozaki M, Hara T, Furuya T and Miyazono K: Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 7: 1191-1204, 2002. (Pubitemid 36024597)
24. Moustakas A and Heldin CH: Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584, 2005.
25. Kundu JK and Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269: 243-261, 2008.
26. Ramassamy C: Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545: 51-64, 2006.
27. Li F, Gong Q, Dong H and Shi J: Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des 18: 27-33, 2012.
28. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B and Sinclair DA: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196, 2003. (Pubitemid 37150899)
29. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M and Sinclair D: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686-689, 2004. (Pubitemid 39061685)
30. Zhang F, Qiu T, Wu X, Wan C, Shi W, Wang Y, Chen JG, Wan M, Clemens TL and Cao X: Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res 24: 1224-1233, 2009.